CLASS I Device recall · Reported 18 May 2016 · FDA Enforcement Report

Vitek Positive Susceptibility Test Cards (AST-P644 recalled

Biomerieux is recalling Vitek Positive Susceptibility Test Cards (AST-P644. The recall was initiated on 24 Feb 2016 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLots 744357740 exp. 9/29/16, 744383620 exp. 6/15/17, and 744389320 exp. 8/11/17.
Quantity recalled5,575 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1645-2016
FDA event ID
73413
Recalling firm
Biomerieux, Hazelwood, MO
Classification
Class I
Status
Terminated
Recall initiated
24 Feb 2016
FDA classified
11 May 2016
Reported
18 May 2016
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

24 Feb 2016Recall initiated by company
11 May 2016Classified by FDA+77 days
18 May 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P644 REF 418673), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Where it was distributed

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

Questions about this recall

Is Vitek Positive Susceptibility Test Cards (AST-P644 recalled?

Yes. Biomerieux recalled Vitek Positive Susceptibility Test Cards (AST-P644 on 24 Feb 2016. The recall is Class I and its status is Terminated. Recall number Z-1645-2016.

Why was it recalled?

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Which lots are affected?

Lots 744357740 exp. 9/29/16, 744383620 exp. 6/15/17, and 744389320 exp. 8/11/17.

Where was it sold?

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biomerieux

All 476

Other Test Kits & Diagnostics recalls

All 2,656